Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Armstrong

Podiatrist Los Angeles, CA Doctor of Podiatric Medicine

NPI 1427160902 CMS profile 110242

1450 San Pablo St Ste 6200, Los Angeles, CA 90033

Open in the dashboard

General payments

$694,935

160 records reported · program years 2019–2025

Research payments

$2,100

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$684,828 paid to institutions, not to them · program years 2019–2024

Through program year 2025, David Armstrong of Los Angeles, CA is reported in the CMS Open Payments database as having received $694,935 across 160 general payments and $2,100 in research payments paid to them. Separately, studies naming them as principal investigator received $684,828 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $97,845 24
2024 General $161,756 36
2023 General $139,940 16
2022 General $25,104 20
2021 General $102,055 36
2021 Research $2,100 1
2020 General $113,572 13
2019 General $54,664 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Armstrong
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to David Armstrong were reported at $97,845. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year David Armstrong Podiatrist median Middle half National median
2019 $54,664 $196 $72–$601 $163
2020 $113,572 $118 $38–$335 $114
2021 $102,055 $169 $57–$573 $132
2022 $25,104 $220 $74–$782 $149
2023 $139,940 $208 $71–$635 $160
2024 $161,756 $237 $87–$681 $164
2025 $97,845 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Podimetrics, Inc. $437,724 6 payments
  2. ConvaTec Inc. $47,555 13 payments
  3. Molnlycke Health Care US, LLC $44,350 9 payments
  4. Nevro Corp. $25,428 20 payments
  5. Cardiovascular Systems Inc. $20,960 9 payments
  6. Kerecis Limited $18,778 8 payments
  7. Endo Pharmaceuticals Inc. $18,573 16 payments
  8. Genzyme Corporation $12,821 1 payment
  9. Vaporox, Inc. $10,000 1 payment
  10. Janssen Scientific Affairs, LLC $8,964 4 payments
  11. Other $49,784 73 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $598,003 65 payments
  2. Grant $30,321 2 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,676 11 payments
  4. Travel and Lodging $24,194 17 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $7,860 4 payments
  6. Honoraria $4,250 2 payments
  7. Food and Beverage $3,607 57 payments
  8. Education $24 2 payments
Products named General payments · program years 2019–2025
  1. SmartMat $50,057 1 payment
  2. AQUACEL AG+ EXTRA $23,343 6 payments
  3. Kerecis Omega3 SurgiClose $18,749 7 payments
  4. INNOVAMATRIX AC $17,966 3 payments
  5. Kerecis Omega3 Marigen Wound Care $17,941 6 payments
  6. Kerecis Omega3 Marigen Wound Care $17,915 5 payments
  7. Kerecis Omega3 Marigen Wound Care $17,915 5 payments
  8. Kerecis Omega3 Marigen Wound Care $17,915 5 payments
  9. Omnia $16,558 14 payments
  10. Diamondback Peripheral $11,160 4 payments
  11. Other $104,483 143 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. PolarityTE, Inc. $2,100 1 payment

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$48,960

Medicare's payments for the services billed

Medicare patients

100

Average age 70

Services billed

480

52 women, 48 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Diabetes 75%
High blood pressure 75%
Arthritis 62%
Chronic kidney disease 53%
Ischemic heart disease 32%
Heart failure 29%
Depression 26%
Osteoporosis 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Qutenza
  • Averitas Pharma Inc. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

161 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record